Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Eli Lilly and Company
- Study ID
- NCT06260722
- Phase
- PHASE3
- Status
- Active Not Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Retatrutide — DRUGAdministered SC.
- Semaglutide — DRUGAdministered SC.
Study Details
The purpose of this study is to investigate the efficacy and safety of retatrutide compared with semaglutide in participants with Type 2 Diabetes and inadequate glycemic control with metformin with or without sodium-glucose cotransporter-2 inhibitor (SGLT2i). The study will last about 26 months and may include up to 24 visits.
Key Dates
- Start date
- Feb 21, 2024
- Status verified
- Apr 2026
- Primary completion
- Aug 31, 2026
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 1,250 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Retatrutide Dose Level 1Participants will receive retatrutide administered subcutaneously (SC).
- Experimental: Retatrutide Dose Level 2Participants will receive retatrutide administered SC.
- Active Comparator: SemaglutideParticipants will receive semaglutide administered SC.
Primary Outcome Measure
Change from Baseline in Hemoglobin A1c (HbA1c) (%) [ Time Frame: Baseline, Week 80 ]
Locations (38)
Find similar trials in Birmingham, AL
By condition
By specialty
By research site
University of Alabama - Department of Nutrition Sciences· Birmingham, ALNeighborhood Healthcare Institute of Health· Escondido, CALong Beach Research Institute· Long Beach, CAValley Clinical Trials, Inc.· Northridge, CARancho Cucamonga Clinical Research· Rancho Cucamonga, CAUniversity of Colorado Anschutz Medical Campus· Aurora, CO
Related Studies
- An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)Enrolling By Invitation · Novo Nordisk A/S · Morgantown, West Virginia
- Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)Recruiting · The University of Texas Health Science Center at San Antonio · San Antonio, Texas
- Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.PHASE2 · Enrolling By Invitation · Columbia University · New York, New York
- Phenotyping Genetic Risk for Type 2 DiabetesRecruiting · University of Pennsylvania · Philadelphia, Pennsylvania